Discover the latest advancements in small cell lung cancer through Novotech CRO’s in-depth disease analysis. Gain valuable insights into novel therapies, ongoing clinical trials, and future ...

The UK is often referred to as the 'sick man of Europe'. And at first glance the description may seem merited. Just last ...

In 33 heavily pretreated NSCLC EGFR wild-type (EGFRwt) patients the combination of AFM24 and atezolizumab shows an overall ...

Researchers have used a chemical compound to light up treatment-resistant cancers on imaging scans, in a breakthrough that ...

PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit looks back on the progress made toward better understanding and ...

You may want to rethink rushing out to buy your favourite Christmas candle. Researchers from Ireland believe making your home ...

Merck & Co Inc (NYSE:MRK) revealed that it would discontinue the clinical development programs for vibostolimab and ...

Asbestos exposure in the workplace can deliver deadly health consequences. It can cause injury or disease, adding to the risk ...

Among the heavily pretreated NSCLC EGFR wild-type patients, the combination therapy demonstrated an overall response rate of 21 percent, and a disease control rate of 76 percent. Moreover, tumor ...

A month after contracting COVID-19 in January 2021, Nicholas Pastuovic was tired, had a severe cough, hot flashes and woke in ...

One LAG-3 drug has reached the market, namely Bristol-Myers Squibb's Opdualag, which combines its PD-1 inhibitor Opdivo ...

Breast cancer continues to pose a significant global health challenge as the most commonly diagnosed cancer in women ...